U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.25%

U.K. stocks rose as Mining, Aerospace & Defense led gains; Pearson reached 5-year highs while Segro hit 52-week lows. Commodities and currency rates remained stable.

Reckitt shares rise on HSBC upgrade

Reckitt Benckiser shares rose over 2% after HSBC upgraded its rating to 'buy,' citing an improved outlook and strategic measures for growth despite challenges in 2024.

Rocket Mortgage sues HUD over appraiser independence issue

Rocket Mortgage has sued HUD over liability issues related to independent appraisals, challenging DOJ claims and seeking clarification on lender responsibilities in appraisal practices.

After-hours movers: Spotify, Rivian, CAVA Group and more

Spotify and CAVA saw significant gains, while ZoomInfo, Rocket Companies, and Instacart faced declines following after-hours earnings reports.

Bernstein downgrades Reckitt; litigation rollercoaster continues

Bernstein downgraded Reckitt Benckiser due to ongoing litigation challenges, adjusting its investment stance to 'market-perform' and lowering the price target amidst increased settlement cost estimates.

Reckitt, Abbott surge after winning an NEC case

A jury ruled that Abbott Laboratories and Mead Johnson are not liable for a young boy's intestinal disease, a significant legal victory amidst ongoing litigation over infant formulas.

Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead

Healthcare helps Reckitt beat quarterly sales estimates

Reckitt reported a smaller than expected drop in Q3 sales, driven by increased health product purchases, despite challenges in its nutrition business and ongoing litigation concerns.

Abbott, Reckitt face trial over premature baby formula amid alarm from doctors

A Missouri mother seeks to hold Abbott and Reckitt accountable for her son's necrotizing enterocolitis linked to their formulas, amid ongoing nationwide litigation over similar cases.